Strategy Asset Managers LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 60.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,254 shares of the medical equipment provider's stock after purchasing an additional 1,231 shares during the quarter. Strategy Asset Managers LLC's holdings in Intuitive Surgical were worth $1,599,000 as of its most recent filing with the SEC.
Other large investors have also modified their holdings of the company. Creekmur Asset Management LLC increased its stake in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 42 shares during the last quarter. Ridgewood Investments LLC purchased a new stake in Intuitive Surgical in the second quarter valued at $26,000. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. LRI Investments LLC acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth about $30,000. Finally, LGT Financial Advisors LLC raised its holdings in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock valued at $30,000 after buying an additional 54 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on the stock. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. Raymond James raised their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a research report on Monday, October 14th. Wells Fargo & Company boosted their price objective on Intuitive Surgical from $466.00 to $549.00 and gave the company an "overweight" rating in a report on Friday, October 18th. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Tuesday. Finally, Mizuho lifted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company's stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and a consensus price target of $524.61.
Read Our Latest Stock Report on Intuitive Surgical
Insider Transactions at Intuitive Surgical
In other news, Director Amy L. Ladd sold 450 shares of the stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the sale, the director now owns 821 shares of the company's stock, valued at $402,519.88. This represents a 35.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the transaction, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. The trade was a 93.06 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 91,178 shares of company stock worth $45,897,071 over the last quarter. 0.80% of the stock is currently owned by insiders.
Intuitive Surgical Price Performance
ISRG traded down $0.03 during trading on Wednesday, reaching $538.79. 437,674 shares of the stock were exchanged, compared to its average volume of 1,454,463. Intuitive Surgical, Inc. has a 1 year low of $304.50 and a 1 year high of $544.38. The company has a market capitalization of $191.91 billion, a price-to-earnings ratio of 86.63, a P/E/G ratio of 5.19 and a beta of 1.39. The business's 50 day moving average price is $501.42 and its two-hundred day moving average price is $460.69.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.